stoxline Quote Chart Rank Option Currency Glossary
  
KORU Medical Systems, Inc. (KRMD)
2.25  -0.01 (-0.44%)    11-29 10:05
Open: 2.25
High: 2.2999
Volume: 5,054
  
Pre. Close: 2.26
Low: 2.25
Market Cap: 103(M)
Technical analysis
2023-11-29 10:17:53 AM
Short term     
Mid term     
Targets 6-month :  2.71 1-year :  2.94
Resists First :  2.32 Second :  2.51
Pivot price 2.22
Supports First :  2 Second :  1.66
MAs MA(5) :  2.28 MA(20) :  2.23
MA(100) :  2.56 MA(250) :  3.31
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  66.6 D(3) :  70.1
RSI RSI(14): 46
52-week High :  4.48 Low :  2
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ KRMD ] has closed below upper band by 41.9%. Bollinger Bands are 35.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.34 - 2.35 2.35 - 2.36
Low: 2.22 - 2.23 2.23 - 2.24
Close: 2.24 - 2.26 2.26 - 2.28
Company Description

KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales and medical device distributors, as well as online. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.

Headline News

Wed, 29 Nov 2023
KORU Medical Systems to Participate in Piper Sandler's 35th ... - WV News

Wed, 29 Nov 2023
KORU Medical Systems to Participate in Piper Sandler's 35th ... - Valdosta Daily Times

Tue, 28 Nov 2023
KORU Medical Systems, Inc. to Host Investor Day on December 5 ... - Joplin Globe

Thu, 09 Nov 2023
KORU Medical Systems, Inc. (NASDAQ:KRMD) Q3 2023 Earnings Call Transcript - Yahoo Finance

Tue, 24 Oct 2023
KORU Medical Systems, Inc.'s (NASDAQ:KRMD) US$14m market value fall may be overlooked by institutional investors after a year of 1.7% returns - Simply Wall St

Thu, 21 Sep 2023
We're Hopeful That KORU Medical Systems (NASDAQ:KRMD) Will Use Its Cash Wisely - Simply Wall St

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical Instruments & Supplies
Shares Out 46 (M)
Shares Float 30 (M)
Held by Insiders 10.2 (%)
Held by Institutions 59.8 (%)
Shares Short 464 (K)
Shares Short P.Month 423 (K)
Stock Financials
EPS -0.19
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.6
Profit Margin -28.8 %
Operating Margin -25.6 %
Return on Assets (ttm) -15.7 %
Return on Equity (ttm) -27.6 %
Qtrly Rev. Growth -9.9 %
Gross Profit (p.s.) 0.33
Sales Per Share 0.62
EBITDA (p.s.) -0.2
Qtrly Earnings Growth 0 %
Operating Cash Flow -5 (M)
Levered Free Cash Flow -1 (M)
Stock Valuations
PE Ratio -12.5
PEG Ratio 0
Price to Book value 3.74
Price to Sales 3.58
Price to Cash Flow -22.1
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android